logo image
search icon
Global Anti-aging Therapeutics Market 2022

Anti-aging Therapeutics Market Size, Share & Trends Analysis Report By Type of Molecule (Biologics, Small Molecules), By Type of Aging (Cellular Aging, Immune Aging, Metabolic Aging, Others), By Mechanism of Action, By Region, And By Segment Forecasts, 2024-2031

Report ID : 1249 | Published : 2024-06-11 | Pages: 180 | Format: PDF/EXCEL

The Anti-aging Therapeutics Market Size is valued at 692.66 Million in 2023 and is predicted to reach 2,527.33 Million by the year 2031 at a 17.62% CAGR during the forecast period for 2024-2031.

Anti-aging treatment combines cutting-edge research and medical technology to identify, prevent, cure, and reverse age-related dysfunctions, illnesses, and diseases as early as possible. As a result, anti-aging preventive medicine and healthcare are critical components in assisting senior people in living healthy and active lives. The progress of technology offers the detection, prevention, and treatment of age-related diseases and the promotion of research into strategies to slow and optimize the human ageing process. Researchers have made considerable progress in understanding stem cell ageing and the molecular processes behind this process during the last decade. Few studies have also validated the extrinsic factors, while transplantation experiments have found the intrinsic components that induce an age-dependent reduction in stem cell quantity and function. 

https://www.insightaceanalytic.com/images_data/320940154.JPG

The rise in consumer demand for anti-aging therapeutics, combined with an increase in lifestyle standards and income among the world's population, is the primary factor driving the growth of the anti-aging therapeutics market over the forecast period. Furthermore, technological advancements and increased investment in research and development activities by major players for the development of highly safe and efficient treatment solutions are expected to propel the anti-aging therapeutics market globally.

Market Segmentation:

The Anti-aging Therapeutics market is segmented on the basis of type of molecule, type of aging and mechanism of action. Based on type of molecule, the market is segmented as Biologics and Small Molecules. The type of aging segment includes Cellular Aging, Immune Aging, Metabolic Aging and Others. By mechanism of action, the market is segmented into Senolytic, Cell Regeneration, mTOR inhibitor/Modulator, AMP-kinase/AMP Activator, Mitochondria Inhibitor/Modulator and Others.

Based on type of molecule, the small molecule segment is accounted as a major contributor in the Anti-aging Therapeutics market

The small molecule segment is accounted as a major contributor in the Anti-aging Therapeutics market. Small molecules can delay multiple aging diseases and increase lifespan. In theory, such molecules could simultaneously prevent dozens of diseases, potentially extending healthy years of life.

Cellular aging segment witnessed growth at a rapid rate

Cellular aging is generally defined as a progressive decrease in resistance to stress and other cellular damages, resulting in a gradual loss of cellular functions and, eventually, cell demise. Cells age as they divide, multiply, and perform their assigned functions. And as they age, the body has remarkable mechanisms in place to care for aging cells and replenish them with new ones.

In the region, the North America Anti-aging Therapeutics market holds a significant revenue share.

The anti-aging therapeutics market in North America is expected to grow significantly due to the availability of well-established infrastructure, key market players, and the region's increasing average life expectancy and median age. However, the rising popularity of anti-aging therapeutics and favorable reimbursement policies are expected to boost regional growth during the forecast period. Furthermore, companies in the region are working hard to improve their market position through R&D and new product launches. Moreover, Asia Pacific is the most populous region on the planet, with a sizable market for anti-aging therapeutics. The development of infrastructure and facilities to advance stem cell research in both developed and emerging nations is driving market expansion in this region.

Competitive Landscape:

Some major key players in the Anti-aging Therapeutics Market:

  • AgelessRx,
  • ANOVA Institute for Regenerative Medicine,
  • Betterhumans,
  • BioAge Labs,
  • BIOPHYTIS BSA,
  • bioXcellerator,
  • Cambrian Biopharma,
  • CytoMed Therapeutics,
  • ai,
  • Rejuvenate Bio,
  • Rejenevie Therapeutics,
  • MyMD Pharmaceuticals,
  • Intervene Immune, Inc.,
  • CohBar, Inc.,
  • Alkahest,
  • Athersys Inc,
  • BHB Therapeutics,
  • Biosplice,
  • Cyclo Therapeutics,
  • Denali Therapeutics,
  • Elysium Health,
  • Genome Protection,
  • GenSight Biologics,
  • Intervene Immune,
  • Khondrian,
  • Longeveron,
  • LyGenesis,
  • Mesoblast,
  • Minovia Therapeutics,
  • Mitobridge,
  • Navitor Pharmaceuticals,
  • NeuroTrack,
  • Nuchido,
  • NuSirt,
  • OneSkin Technologies,
  • PharmatrophiX,
  • Proteostasis Therapeutics,
  • Retrotope,
  • Stealth Biotherapeutics,
  • TA Sciences,
  • Unity Biotechnology
  • Younger Phenotype,
  • Other Prominent Players.

Anti-aging Therapeutics Market Report Scope:

Report Attribute

Specifications

Market size value in 2022

USD 692.66 Million

Revenue forecast in 2031

USD 2,527.33 Million

Growth rate CAGR

CAGR of 17.62% from 2024 to 2031

Quantitative units

Representation of revenue in US$ Million and CAGR from 2024 to 2031

Historic Year

2019 to 2023

Forecast Year

2024-2031

Report coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments covered

Type of Molecule, Type of Aging, Mechanism of Action

Regional scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Competitive Landscape

AgelessRx, ANOVA Institute for Regenerative Medicine, Betterhumans, BioAge Labs, BIOPHYTIS BSA, bioXcellerator, Cambrian Biopharma, CytoMed Therapeutics, Gero.ai, Rejuvenate Bio, Rejenevie Therapeutics, MyMD Pharmaceuticals, Intervene Immune, Inc., CohBar, Inc., Alkahest, Athersys Inc, BHB Therapeutics, Biosplice, Cyclo Therapeutics, Denali Therapeutics, Elysium Health, Genome Protection, GenSight Biologics, Intervene Immune, Khondrian, Longeveron, LyGenesis, Mesoblast, Minovia Therapeutics, Mitobridge, Navitor Pharmaceuticals, NeuroTrack, Nuchido, NuSirt, OneSkin Technologies, PharmatrophiX, Proteostasis Therapeutics, Retrotope, Stealth Biotherapeutics, TA Sciences, Unity BiotechnologyYounger Phenotype, and Other Prominent Players.

Customization scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing and available payment methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Anti-aging Therapeutics Market Snapshot

Chapter 4. Global Anti-aging Therapeutics Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: By Molecule, Estimates & Trend Analysis

5.1. By Molecules, & Market Share, 2023 & 2031

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Molecules:

5.2.1. Biologics

5.2.2. Small Molecules

Chapter 6. Market Segmentation 2: By Aging Types Estimates & Trend Analysis

6.1. By Aging Types & Market Share, 2023 & 2031

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Aging Types:

6.2.1. Cellular Aging

6.2.2. Immune Aging

6.2.3. Metabolic Aging

6.2.4. Other Aging Types

Chapter 7. Market Segmentation 3: By Mechanism of Action Estimates & Trend Analysis

7.1. By Mechanism of Action & Market Share, 2023 & 2031

7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Mechanism of Action:

7.2.1. Senolytic

7.2.2. Cell Regeneration

7.2.3. mTOR inhibitor/Modulator

7.2.4. AMP-kinase/AMP Activator

7.2.5. Mitochondria Inhibitor/Modulator

7.2.6. other Mechanism of Action

Chapter 8. Anti-aging Therapeutics Market Segmentation 4: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Anti-aging Therapeutics Market revenue (US$ Million) estimates and forecasts By Molecules, 2024-2031

8.1.2. North America Anti-aging Therapeutics Market revenue (US$ Million) estimates and forecasts By Aging Types, 2024-2031

8.1.3. North America Anti-aging Therapeutics Market revenue (US$ Million) estimates and forecasts By Mechanism of Action, 2024-2031

8.1.4. North America Anti-aging Therapeutics Market revenue (US$ Million) estimates and forecasts by country, 2024-2031

8.2. Europe

8.2.1. Europe Anti-aging Therapeutics Market revenue (US$ Million) By Molecules, 2024-2031

8.2.2. Europe Anti-aging Therapeutics Market revenue (US$ Million) By Aging Types, 2024-2031

8.2.3. Europe Anti-aging Therapeutics Market revenue (US$ Million) By Mechanism of Action, 2024-2031

8.2.4. Europe Anti-aging Therapeutics Market revenue (US$ Million) by country, 2024-2031

8.3. Asia Pacific

8.3.1. Asia Pacific Anti-aging Therapeutics Market revenue (US$ Million) By Molecules, 2024-2031

8.3.2. Asia Pacific Anti-aging Therapeutics Market revenue (US$ Million) By Aging Types, 2024-2031

8.3.3. Asia Pacific Anti-aging Therapeutics Market revenue (US$ Million) By Mechanism of Action, 2024-2031

8.3.4. Asia Pacific Anti-aging Therapeutics Market revenue (US$ Million) by country, 2024-2031

8.4. Latin America

8.4.1. Latin America Anti-aging Therapeutics Market revenue (US$ Million) By Molecules, (US$ Million) 2024-2031

8.4.2. Latin America Anti-aging Therapeutics Market revenue (US$ Million) By Aging Types, (US$ Million) 2024-2031

8.4.3. Latin America Anti-aging Therapeutics Market revenue (US$ Million) By Mechanism of Action, (US$ Million) 2024-2031

8.4.4. Latin America Anti-aging Therapeutics Market revenue (US$ Million) by country, 2024-2031

8.5. Middle East & Africa

8.5.1. Middle East & Africa Anti-aging Therapeutics Market revenue (US$ Million) By Molecules, (US$ Million) 2024-2031

8.5.2. Middle East & Africa Anti-aging Therapeutics Market revenue (US$ Million) By Aging Types, (US$ Million) 2024-2031

8.5.3. Middle East & Africa Anti-aging Therapeutics Market revenue (US$ Million) By Mechanism of Action, (US$ Million) 2024-2031

8.5.4. Middle East & Africa Anti-aging Therapeutics Market revenue (US$ Million) by country, 2024-2031

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

 9.2.1. AgelessRx

9.2.2. ANOVA Institute for Regenerative Medicine

9.2.3. Betterhumans

9.2.4. BioAge Labs

9.2.5. BIOPHYTIS BSA

9.2.6. bioXcellerator

9.2.7. Cambrian Biopharma

9.2.8. CytoMed Therapeutics

9.2.9. Gero.ai

9.2.10. Rejuvenate Bio

9.2.11. Rejenevie Therapeutics

9.2.12. UT Health San Antonio

9.2.13. MyMD Pharmaceuticals

9.2.14. Intervene Immune, Inc.

9.2.15. CohBar, Inc.

9.2.16. Alkahest

9.2.17. Athersys Inc

9.2.18. BHB Therapeutics

9.2.19. Biosplice

9.2.20. Cyclo Therapeutics

9.2.21. Denali Therapeutics

9.2.22. Elysium Health

9.2.23. Genome Protection

9.2.24. GenSight Biologics

9.2.25. Intervene Immune

9.2.26. Khondrian

9.2.27. Longeveron

9.2.28. LyGenesis

9.2.29. Mesoblast

9.2.30. Minovia Therapeutics

9.2.31. Mitobridge

9.2.32. Navitor Pharmaceuticals

9.2.33. NeuroTrack

9.2.34. Nuchido

9.2.35. NuSirt

9.2.36. OneSkin Technologies

9.2.37. PharmatrophiX

9.2.38. Proteostasis Therapeutics

9.2.39. Retrotope

9.2.40. Stealth Biotherapeutics

9.2.41. TA Sciences

9.2.42. Unity Biotechnology

9.2.43. Younger Phenotype

9.2.44. Other Prominent Players

 

Segmentation of Anti-aging Therapeutics Market-

By Type of Molecule

  • Biologics
  • Small Molecules 

https://www.insightaceanalytic.com/images_data/382510716.JPG

By Type of Aging

  • Cellular Aging
  • Immune Aging
  • Metabolic Aging
  • Others

By Mechanism of Action

  • Senolytic
  • Cell Regeneration
  • mTOR inhibitor/Modulator
  • AMP-kinase/AMP Activator
  • Mitochondria Inhibitor/Modulator
  • Others 

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Anti-aging Therapeutics Market?

Anti-aging Therapeutics Market expected to grow at 17.62% CAGR during the forecast period for 2024-2031

AgelessRx, ANOVA Institute for Regenerative Medicine, Betterhumans, BioAge Labs, BIOPHYTIS BSA, bioXcellerator, Cambrian Biopharma, CytoMed Therapeuti

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Pharmaceuticals

Select Licence Type
$4500
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach